BioGene Therapeutics Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-08-078/7/26 | New | $3,000,000 | $3,000,000 | Other | 06b | SEC linkSEC |
| 2026-08-068/6/26 | New | $250,000 | $250,000 | Other | 06b | SEC linkSEC |
| 2026-08-068/6/26 | New | $250,000 | $250,000 | Other | 06b | SEC linkSEC |
| 2026-08-068/6/26 | New | $3,000,000 | $3,000,000 | Other | 06b | SEC linkSEC |
| 2026-07-237/23/26 | New | $4,550,000 | $4,550,000 | Other | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Steve Glover | Director |
| David Tyronne Howton | Director |
| Patroski Lawson | Director |
| Raj Pruthi | Director |
| Deepak Sampath | Director |
| Stephen Van Deventer | Director, Executive |
Industry: Biotechnology (See others in industry)
Address:
5900 Balcones Dr, Ste 100
Austin, TX, 78731
Phone: 1-512-379-7526
Austin, TX, 78731
Phone: 1-512-379-7526